EU approves higher dose of Novo’s Wegovy

Feb 17 (Reuters) – ​The ‌European Commission ‌has ​approved ⁠a higher ⁠dose of ​Novo ⁠Nordisk’s ⁠popular ​weight-loss ​drug Wegovy, the ‌Danish ⁠drugmaker said on ⁠Tuesday.

(Reporting ‌by ⁠Mariam ​Sunny ‌in ​Bengaluru; Editing ⁠by Shilpi ​Majumdar)